ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




2024Äê5ÔÂ14-16ÈÕ£¬£¬£¬£¬£¬APPLIED PHARMACEUTICAL TOXICOLOGY (APT) 2024 ½«ÔÚMerck Research Laboratories, Boston, MA¾ÙÐС£¡£¡£¡£¡£ÃÀ¸ß÷ִÐи±×ܲüæÃÀ¹ú¹«Ë¾×ܲÃÁÖÇì´Ï²©Ê¿ÊÜÑû³öϯ´Ë´Î¾Û»á£¬£¬£¬£¬£¬²¢½ø´øÀ´¡° Preclinical Safety Evaluation for Antibody Drug Conjugates (ADCs)¡±¾«²ÊÑݽ²£¬£¬£¬£¬£¬Õ¹Ê¾ÃÀ¸ß÷ADCһվʽÑз¢Ð§ÀÍÄÜÁ¦¡£¡£¡£¡£¡£
ͬʱ£¬£¬£¬£¬£¬ÃÀ¸ß÷ÃÀ¹úÍŶÓÒ²ÁÁÏàÏÖ³¡£¬£¬£¬£¬£¬Í¨¹ýÏÖ³¡Õ¹Ì¨»¥¶¯µÈ·½·¨ºÍÈ«ÇòADCÐÐÒµ´ó¿§¾ÙÐÐÉîÈë½»Á÷ºÍ̽ÌÖ£¬£¬£¬£¬£¬Ò»Á¬¸³ÄÜÐÐÒµ£¬£¬£¬£¬£¬¼ÓËÙADCÒ©ÎïÑз¢Àú³Ì¡£¡£¡£¡£¡£
ÃÀ¸ß÷ÔÚADCÁìÓòÉî¸û¶àÄ꣬£¬£¬£¬£¬ÓµÓÐÂÄÀú¸»ºñµÄ¼¼ÊõÍŶӺͺϳÉÂÄÀú£¬£¬£¬£¬£¬¹¹½¨Á˸»ºñ¶àÑùµÄADC¿â¡£¡£¡£¡£¡£×èÖ¹2024Äê4Ô£¬£¬£¬£¬£¬ÃÀ¸ß÷ÒÑÀÖ³ÉÖúÁ¦24¸öADCÒ©Îï»ñÅúÁÙ´²£¬£¬£¬£¬£¬²¢Óжà¸öADCÏîÄ¿ÔÚÑС£¡£¡£¡£¡£»£»£»£»£»£»¶ÓÒµÄÚͬÈʽìʱÓë»á½»Á÷£¡
ʱ¼ä | 5ÔÂ14-16ÈÕ
ËùÔÚ | Merck Research Laboratories, Boston, MA
ÃÀ¸ß÷չλ#3£¬£¬£¬£¬£¬²»¼û²»É¢£¡


ÃÀ¸ß÷ÔÚADCµÄÁÙ´²Ç°Ò»Ì廯Ñо¿¼Æ»®Öƶ©ÖÐÓë¿Í»§ÉîÈë½»Á÷£¬£¬£¬£¬£¬¿ÆÑÐÖ÷¸É½«Ã¿Ò»¸ö°¸ÀýµÄÌØµãÓë¶àÄêʵսÂÄÀúºÍ¼¼Êõ»ýÀÛÏàÁ¬Ïµ£¬£¬£¬£¬£¬ÉóÉ÷µØ½«ÓÅÖÊʵÑ鼯»®ÓëЧ¹ûÌá½»µ½¿Í»§ÊÖÉÏ¡£¡£¡£¡£¡£ÃÀ¸ß÷¿ÉÒÔΪ¿Í»§ÌṩADC PayloadsºÏ³É¡¢ADCÒ©ÎïżÁª¡¢ADCҩЧѧÆÀ¼Û¡¢ADCÒ©´ú¶¯Á¦Ñ§ÆÀ¼ÛºÍADCÇå¾²ÐÔÆÀ¼ÛµÈЧÀÍ¡£¡£¡£¡£¡£×èÖ¹ÏÖÔÚ£¬£¬£¬£¬£¬ÃÀ¸ß÷³Ð½ÓµÄINDÉ걨ÀàÉúÎïÒ©´óÏîÄ¿ÒѾ100¶àÏ£¬£¬£¬£¬°üÀ¨µ¥¿¹¡¢Ë«¿¹¡¢¶à¿¹¡¢ADC¡¢²¡¶¾ÒßÃçºÍÈÚºÏÂѰ׵ȡ£¡£¡£¡£¡£
ADC LinkersÏÖ»õ²úÆ·
ÖþÒ©ÍøÊÇADCÏà¹Ø²úÆ·¶¨ÖƺÍЧÀ͹©Ó¦ÉÌ£¬£¬£¬£¬£¬ÓµÓÐR&DʵÑéÊҺ͸߻îÐÔÒ©ÎïÉú²úÄÜÁ¦£¬£¬£¬£¬£¬¿ÆÑÐÍŶÓÓµÓÐרҵ¸»ºñµÄ»¯Ñ§ÐÞÊμ¼ÊõºÍÄÜÁ¦£¬£¬£¬£¬£¬ÔÚ¿â¶¾ËØºÍÅþÁ¬×Ó¿ÉÒÔΪ¿Í»§Öª×ã´ÓºÁ¿Ëµ½Ç§¿Ë¼¶Ñз¢ÐèÇ󣬣¬£¬£¬£¬ÊµÏÖ´ÓÒ©ÎïÑз¢¹âÁÙ´²Ç°CMCÉú²úµÄÈ«Àú³ÌЧÀÍ£¬£¬£¬£¬£¬½µµÍÑз¢±¾Ç®£¬£¬£¬£¬£¬Ìá¸ßÒ©ÎïÑз¢ËÙÂʺÍЧÂÊ¡£¡£¡£¡£¡£
Ñ¡¹º²úÆ·
Ïà¹ØÐÂÎÅʱ¼ä£º2020Äê12ÔÂ09-10ÈÕ
ËùÔÚ£ºÉϺ£ÆÖ¶«Â̵ز¬æêÂùÝ
ʱ¼ä£º2018Äê10ÔÂ25ÈÕ 14:00-16:00
ËùÔÚ£º´óÐËÇø±±¾©ÒàׯÉúÎïÒ½Ò©Ô°¿§·ÈÌü